Shenzhen Guozhong Venture Capital Management
VC Fund
Shenzhen, China
Shenzhen Guozhong Venture Capital Management is a VC fund in Shenzhen focused on Manufacturing and Health Care. Shenzhen Guozhong Venture Capital Management CO. LTD.(GZVCM) was founded on 21st of December 2015, currently being entrusted to manage the first entity fund of Small Medium Enterprises Development Fund（SHENZHEN）LLP with a size of 6 Billion Yuan.Guozhong Venture Capital with a registered size of 100million Yuan, partners consisting Shenzhenventure capital group (49%) and the management team of Small Medium Enterprise Development Fund (SHENZHEN) (51%).
- Total investments:
- 129
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Shenzhen Guozhong Venture Capital Management invests in
Stages Shenzhen Guozhong Venture Capital Management invests in
Countries Shenzhen Guozhong Venture Capital Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $61k–$14M
- Series A
- $211k–$41M
- Series B
- $11M–$71M
Investment Focus
Industry
- Manufacturing 26 (20%)
- Health Care 19 (15%)
- Biotechnology 15 (12%)
- Semiconductor 15 (12%)
- Medical 13 (10%)
Stage
- Series A 42 (33%)
- Series B 32 (25%)
- Seed 14 (11%)
- Series C 9 (7%)
- Angel 5 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Anping Shi
Chief Partner, CEO
|
Chief Partner, CEO | Total investments: 0 | Find email | |
|
Gao Bo
head
|
head | Total investments: 1 | Find email | |
|
Lin Xiangfeng
Executive general manager
|
Executive general manager | Total investments: 1 | Find email | |
|
Ma Ruopeng
Partner
|
Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ractigen Therapeutics
|
Ractigen is an early-stage pharmaceutical company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery made at the University of California San Francisco (UCSF) known as RNA activation(RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need. | $31M / Venture - Series Unknown / Jul 29, 2026 | |
SpinQ Technology
|
SpinQ Technology develops superconducting chip quantum computers, desktop nuclear magnetic resonance quantum computers, and quantum computing-related software. | $147.2M / Series D / Jun 30, 2026 | |
Raypaitech
|
Raypaitech is a augmented reality system solutions software and hardware development company. | Series B / Jun 26, 2026 | |
Huixin Laser Technology
|
Huixin Laser is a company specializes in the independent research, development, and production of high-end compound semiconductor optoelectronic chips. Its primary products include vertical cavity surface emitting laser (VCSEL) chips for 3D sensing, high-speed VCSEL chips, high-speed distributed feedback laser (DFB) chips, electro-absorptionmodulated laser (EML) chips, and high-speed photodetector (PD) chips. | Series A / Jun 23, 2026 | |
GigaAI
|
Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space. | $147.9M / Series B / Jun 15, 2026 | |
|
Zhiwei Innovation
|
Zhiwei Innovation specializes in the semiconductor/EDA domain, providing an important infrastructure layer for chip design. | Angel / Jun 04, 2026 | |
iSpace China
|
iSpace designs and develops commercial space shuttle. | $727.6M / Series D / Feb 09, 2026 | |
|
Ion Energy
|
Ion Energy is a high-tech company focused on the research, development, and use of polymer-based solid electrolyte materials and all-solid-state batteries. | Seed / Jan 21, 2026 | |
Senas Medical
|
Senas Medical focuses on innovative cardiac electrophysiology solutions. | $14.3M / Series A / Jan 16, 2026 | |
|
Han'ao Intelligent
|
Han'ao Intelligent focus on electrolytic milling + five-axis/multi-axis linkage technology. | Angel / Jan 06, 2026 | |
| See all 129 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Shenzhen Guozhong Venture Capital Management invest in?
Shenzhen Guozhong Venture Capital Management invests primarily in Manufacturing, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 129 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Shenzhen Guozhong Venture Capital Management's check size?
Shenzhen Guozhong Venture Capital Management typically joins rounds of $61k–$14M at Seed, $211k–$41M at Series A and $11M–$71M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Shenzhen Guozhong Venture Capital Management participates in.
How do I contact Shenzhen Guozhong Venture Capital Management?
Public channels for Shenzhen Guozhong Venture Capital Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Shenzhen Guozhong Venture Capital Management?
The team at Shenzhen Guozhong Venture Capital Management includes Anping Shi (Chief Partner, CEO), Gao Bo (head) and Lin Xiangfeng (Executive general manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
